SD Biosensor Inc (137310.KS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · South Korea · ISIN KR7137310009

Price
6,755.00 KRW
Market cap
808.03 bn KRW
P/E (2025)
–
P/S (2025)
1.14
Dividend yield
2.96 %
Net margin
-72.07 %
Return on equity (ROE)
-21.98 %
Return on assets (ROA)
-15.79 %

SD Biosensor Inc financials

Fiscal year20242025
Revenue694.57 bn KRW710.58 bn KRW
Gross profit339.39 bn KRW325.53 bn KRW
Operating income-54.06 bn KRW-80.95 bn KRW
EBIT-150.59 bn KRW-809.91 bn KRW
Net income-98.41 bn KRW-512.11 bn KRW
Diluted EPS – continuing operations-804.36 KRW-4,281.14 KRW

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About SD Biosensor Inc

SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides STANDARD i, an analyzer based on chemiluminescence immunoassay technology for detection of clinical biomarkers, including hormones, tumor markers, and infectious diseases; blood glucose meter products; and other products, such as transport medium, d-BLOCK incubator, G6PD analyzer, LipidoCare analyzer, MultiCare analyzer, and Pilot COVID-19 at-home test. The company exports its products. SD Biosensor, Inc. was founded in 1999 and is headquartered in Suwon-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.